Learning and memory in 5-HT1A-receptor mutant mice

Behavioural Brain Research

Volumn 195, Issue 1, 2008, Pages 78-85

  Bert, B ^a   Fink, H ^a   Rothe, J ^a   Walstab, J ^b   Bonisch H ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

5 HT1A receptor; 8 OH DPAT; Learning and memory; Overexpression; Transgenic mice

Indexed keywords

SEROTONIN 1A RECEPTOR;

ANXIETY DISORDER; ARTICLE; BRAIN REGION; DEPRESSION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; KNOCKOUT MOUSE; LEARNING; MEMORY; MOUSE MUTANT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; LEARNING; MEMORY; MICE; MICE, TRANSGENIC; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS;

EID: 52949136219     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.02.028     Document Type: Article

References (91)

1. Ago Y., Koyama Y., Baba A., and Matsuda T. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
2. Albert P.R., Zhou Q.Y., Van Tol H.H., Bunzow J.R., and Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 265 (1990) 5825-5832
3. Arvidsson L.E., Hacksell U., Nilsson J.L., Hjorth S., Carlsson A., Lindberg P., et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24 (1981) 921-923
4. Bert B., Dere E., Wilhelmi N., Kusserow H., Theuring F., Huston J.P., et al. Transient overexpression of the 5-HT(1A) receptor impairs water-maze but not hole-board performance. Neurobiol Learn Mem 84 (2005) 57-68
5. Bert B., Fink H., Hortnagl H., Veh R.W., Davies B., Theuring F., et al. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. Behav Brain Res 167 (2006) 328-341
6. Bert B, Voigt JP, Kusserow H, Theuring F, Rex A, Fink H. Relevance of the postsynaptic 5-HT1A-receptor for learning and memory revealed in 5-HT1A-receptor overexpressing mice. Neurobiol Learn Mem; submitted for publication.
7. Beuzen A., and Belzung C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiol Behav 58 (1995) 111-118
8. Bill D.J., Knight M., Forster E.A., and Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103 (1991) 1857-1864
9. Blanchard R.J., Shepherd J.K., Armstrong J., Tsuda S.F., and Blanchard D.C. An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT. Psychopharmacology (Berl) 112 (1993) 55-63
10. Blier P., and de Montigny C. Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists. J Cardiovasc Pharmacol 15 Suppl. 7 (1990) S42-S48
11. Blier P., Seletti B., Gilbert F., Young S.N., and Benkelfat C. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. Neuropsychopharmacology 27 (2002) 301-308
12. Borg J., Andree B., Lundberg J., Halldin C., and Farde L. Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions-a strategy in translational psychopharmacology. Psychopharmacology (Berl) 185 (2006) 389-394
13. Brooks S.P., Pask T., Jones L., and Dunnett S.B. Behavioural profiles of inbred mouse strains used as transgenic backgrounds II: cognitive tests. Genes Brain Behav 4 (2005) 307-317
14. Carli M., and Samanin R. 8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Br J Pharmacol 105 (1992) 720-726
15. Carli M., Luschi R., and Samanin R. (S)-WAY, 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur J Neurosci 283 (1995) 133-139
16. Carli M., Bonalumi P., and Samanin R. WAY, 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 774 (1997) 167-174
17. Carli M., Balducci C., Millan M.J., Bonalumi P., and Samanin R. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br J Pharmacol 128 (1999) 1207-1214
18. Carli M., Balducci C., and Samanin R. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats. Psychopharmacology (Berl) 158 (2001) 39-47
19. Chessell I.P., Francis P.T., Pangalos M.N., Pearson R.C., and Bowen D.M. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones. Brain Res 632 (1993) 86-94
20. Childers Jr. W.E., Abou-Gharbia M.A., Kelly M.G., Andree T.H., Harrison B.L., Ho D.M., et al. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan. J Med Chem 48 (2005) 3467-3470
21. Consolo S., Ramponi S., Ladinsky H., and Baldi G. A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res 707 (1996) 320-323
22. Czyrak A., Czepiel K., Mackowiak M., Chocyk A., and Wedzony K. Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 989 (2003) 42-51
23. De Vry J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl) 121 (1995) 1-26
24. De Vry J., Schreiber R., Melon C., Dalmus M., and Jentzsch K.R. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14 (2004) 487-495
25. Deng D.R., Djalali S., Holtje M., Grobetae G., Stroh T., Voigt I., et al. Embryonic and postnatal development of the serotonergic raphe system and its target regions in 5-HT(1A) receptor deletion or overexpressing mouse mutants. Neuroscience 147 (2007) 388-402
26. Dirks A., Pattij T., Bouwknecht J.A., Westphal T.T., Hijzen T.H., Groenink L., et al. 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response. Behav Brain Res 118 (2001) 169-178
27. Dulawa S.C., and Geyer M.A. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39 (2000) 2170-2179
28. Dulawa S.C., Gross C., Stark K.L., Hen R., and Geyer M.A. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22 (2000) 650-659
29. Egashira N., Yano A., Ishigami N., Mishima K., Iwasaki K., Fujioka M., et al. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Res 1069 (2006) 54-62
30. Evenden J.L., and Angeby-Moller K. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology (Berl) 102 (1990) 485-491
31. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14 (1991) 220-223
32. Fink K.B., and Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59 (2007) 360-417
33. Francis P. Targeting cell death in dementia. Alzheimer Dis Assoc Disord 20 (2006) S3-S7
34. Fujii T., Yoshizawa M., Nakai K., Fujimoto K., Suzuki T., and Kawashima K. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res 761 (1997) 244-249
35. Goodwin G.M., De Souza R.J., and Green A.R. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Neuropharmacology 24 (1985) 1187-1194
36. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (2002) 396-400
37. Gsell W., Jungkunz G., and Riederer P. Functional neurochemistry of Alzheimer's disease. Curr Pharm Des 10 (2004) 265-293
38. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 15049-15054
39. Hillegaart V., Wadenberg M.L., and Ahlenius S. Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol, Biochem, Behav 32 (1989) 797-800
40. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J Neural Transm 61 (1985) 131-135
41. Izumi J., Washizuka M., Miura N., Hiraga Y., and Ikeda Y. Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats. J Neurochem 62 (1994) 1804-1808
42. Kasper S., Tauscher J., Willeit M., Stamenkovic M., Neumeister A., Kufferle B., et al. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder-implications for psychopharmacology. World J Biol Psychiatry 3 (2002) 133-146
43. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., et al. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proceedings of the National Academy of Sciences of the United States of America, vol. 103 (2006) 702-707
44. Klemenhagen K.C., Gordon J.A., David D.J., Hen R., and Gross C.T. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 31 (2006) 101-111
45. Kusserow H., Davies B., Hortnagl H., Voigt I., Stroh T., Bert B., et al. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res Mol Brain Res 129 (2004) 104-116
46. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., et al. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 974 (2003) 82-87
47. Lanctot K.L., Hussey D.F., Herrmann N., Black S.E., Rusjan P.M., Wilson A.A., et al. A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease. Am J Geriatr Psychiatry (2007)
48. McLoughlin D.M., Lucey J.V., and Dinan T.G. Central serotonergic hyperresponsivity in late-onset Alzheimer's disease. Am J Psychiatry 151 (1994) 1701-1703
49. Meller E., Goldstein M., and Bohmaker K. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37 (1990) 231-237
50. Meller E., Chalfin M., and Bohmaker K. Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance. Pharmacol, Biochem, Behav 43 (1992) 405-411
51. Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 23 (1999) 1111-1125
52. Meneses A., and Perez-Garcia G. 5-HT(1A) receptors and memory. Neurosci Biobehav Rev 31 (2007) 705-727
53. Micheau J., and Van Marrewijk B. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Prog Neuropsychopharmacol Biol Psychiatry 23 (1999) 1113-1133
54. Millan M.J., Rivet J.M., Canton H., Lejeune F., Gobert A., Widdowson P., et al. S 15535, a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively. Eur J Pharmacol 230 (1993) 99-102
55. Millan M.J., Gobert A., Roux S., Porsolt R., Meneses A., Carli M., et al. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis. J Pharmacol Exp Ther 311 (2004) 190-203
56. Misane I., Johansson C., and Ogren S.O. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol 125 (1998) 499-509
57. Mittman S.M., and Geyer M.A. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology (Berl) 98 (1989) 321-329
58. Moller M., Jakobsen S., and Gjedde A. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology 32 (2007) 1707-1714
59. Musial A., Bajda M., and Malawska B. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 14 (2007) 2654-2679
60. Nakai K., Fujii T., Fujimoto K., Suzuki T., and Kawashima K. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis. Neurosci Res 31 (1998) 23-29
61. Olivier B., Zethof T., Pattij T., van Boogaert M., van Oorschot R., Leahy C., et al. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463 (2003) 117-132
62. O'Neill C., Cowburn R.F., Wiehager B., Alafuzoff I., Winblad B., and Fowler C.J. Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease. Neurosci Lett 133 (1991) 15-19
63. Overstreet D.H., Commissaris R.C., De La Garza II R., File S.E., Knapp D.J., and Seiden L.S. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6 (2003) 101-110
64. Parks C.L., Robinson P.S., Sibille E., Shenk T., and Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 10734-10739
65. Pattij T., Broersen L.M., van der Linde J., Groenink L., van der Gugten J., Maes R.A., et al. Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice. Behav Brain Res 141 (2003) 137-145
66. Pitsikas N., Rigamonti A.E., Cella S.G., and Muller E.E. The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Brain Res 983 (2003) 215-222
67. Pompeiano M., Palacios J.M., and Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12 (1992) 440-453
68. Raje S., Patat A.A., Parks V., Schechter L., Plotka A., Paul J., et al. A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT(1A) receptors in healthy young and elderly subjects, and in patients With Alzheimer's disease. Clin Pharmacol Ther (2007)
69. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 14476-14481
70. Riederer P., and Hoyer S. From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm 113 (2006) 1671-1677
71. Sakaue M., Somboonthum P., Nishihara B., Koyama Y., Hashimoto H., Baba A., et al. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br J Pharmacol 129 (2000) 1028-1034
72. Sarnyai Z., Sibille E.L., Pavlides C., Fenster R.J., McEwen B.S., and Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proceedings of the National Academy of Sciences of the United States of America, vol. 97 (2000) 14731-14736
73. Schechter L.E., Dawson L.A., and Harder J.A. The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease. Curr Pharm Des 8 (2002) 139-145
74. Schechter L.E., Smith D.L., Rosenzweig-Lipson S., Sukoff S.J., Dawson L.A., Marquis K., et al. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J Pharmacol Exp Ther 314 (2005) 1274-1289
75. Sprouse J.S., and Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27 (1988) 707-715
76. Steckler T., and Sahgal A. How do glutamateric drugs affect cognitive function? Commentary on Danysz et al., 'Modulation of learning processes by ionotropic glutamate receptor ligands'. Behav Pharmacol 6 (1995) 475-477
77. Sumiyoshi T., Matsui M., Nohara S., Yamashita I., Kurachi M., Sumiyoshi C., et al. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158 (2001) 1722-1725
78. Sumiyoshi T., Matsui M., Yamashita I., Nohara S., Kurachi M., Uehara T., et al. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry 49 (2001) 861-868
79. Suzuki M., Matsuda T., Asano S., Somboonthum P., Takuma K., and Baba A. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation. Br J Pharmacol 115 (1995) 703-711
80. Tada K., Kasamo K., Suzuki T., Matsuzaki Y., and Kojima T. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors. Hippocampus 14 (2004) 143-147
81. Tanaka E., and North R.A. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69 (1993) 1749-1757
82. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., et al. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 24 (2001) 522-530
83. Truchot L., Costes S.N., Zimmer L., Laurent B., Le Bars D., Thomas-Anterion C., et al. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment. Neurology 69 (2007) 1012-1017
84. Tsetsenis T., Ma X.H., Lo Iacono L., Beck S.G., and Gross C. Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus. Nat Neurosci 10 (2007) 896-902
85. Van den Hooff P., and Galvan M. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro. Br J Pharmacol 106 (1992) 893-899
86. Walton H.S., and Dodd P.R. Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int 50 (2007) 1052-1066
87. Wedzony K., Chocyk A., Kolasiewicz W., and Mackowiak M. Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein. J Physiol Pharmacol 58 (2007) 611-624
88. Weinstein D., Magnuson D., and Lee J. Altered G-protein coupling of a frontal cortical low affinity [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin serotonergic binding site in Alzheimer's disease. Behav Brain Res 73 (1996) 325-329
89. Wolff M., Costet P., Gross C., Hen R., Segu L., and Buhot M.C. Age-dependent effects of serotonin-1A receptor gene deletion in spatial learning abilities in mice. Brain Res Mol Brain Res 130 (2004) 39-48
90. Yamada J., Sugimoto Y., and Horisaka K. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Eur J Pharmacol 154 (1988) 299-304
91. Yasuno F., Suhara T., Nakayama T., Ichimiya T., Okubo Y., Takano A., et al. Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. Am J Psychiatry 160 (2003) 334-340